Loading...
XNAS
SIBN
Market cap853mUSD
Dec 05, Last price  
19.68USD
1D
2.29%
1Q
20.81%
IPO
-6.29%
Name

SI-BONE Inc

Chart & Performance

D1W1MN
XNAS:SIBN chart
P/E
—
P/S
5.11
EPS
—
Div Yield, %
—
Shrs. gr., 5y
10.91%
Rev. gr., 5y
19.96%
Revenues
167m
+20.37%
37,016,00048,999,00040,054,00041,173,00042,101,00047,983,00055,380,00067,301,00073,387,00090,152,000106,409,000138,886,000167,178,000
Net income
-31m
L-28.67%
-10,903,000-6,154,000-27,806,000-28,154,000-20,589,000-23,039,000-17,453,000-42,576,000-48,542,000-60,128,000-62,903,000-43,336,000-30,913,000
CFO
-12m
L-33.60%
-14,759,000-566,000-26,327,000-26,718,000-16,753,000-17,530,000-14,519,000-31,627,000-30,662,000-39,533,000-41,655,000-18,713,000-12,425,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
URL
https://si-bone.com/
IPO date
Oct 17, 2018
Employees
357
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT